Dr Tariro Makadzange, a 2007 Tutu Fellow, has participated in the development of Zimbabwe's Guidelines for the Management of COVID-19. She worked with the Physicians Association (NAPAZ) and the Essential Medicines List (EDLIZ), submitting inputs. The document is published by the National Medicine and Therapeutics Policy Advisory Committee of the Zimbabe Ministry of Health. The document will serve as the national guide and standard for Zimbabwe for management of COVID-19 pandemic.
The foreword says the document reflects the consensus of local experts, and takes into consideration factors such as the Zimbabwean setting, prevailing economic climate, practical experience as well as evidence-based therapeutics.
The guidelines took into consideration the current trends and science for the novel disease and Version 2, which was released in April, is to be updated as ongoing research progresses and clinical trials produce new evidence. The guidelines are aimed at all health workers in Zimbabwe.
Tariro is an infectious disease physician scientist and Director of Biology at the multinational biopharmaceutical company, Gilead Sciences. She has held positions as an Instructor in Medicine at Harvard Medical School; Assistant in Medicine at Massachusetts General Hospital; Boston Faculty; Ragon Institute of MGH, MIT; University of Zimbabwe College of Health Sciences Consultant; and a Physician at Parirenyatwa Hospital and Parirenyatwa Hospital Family Care Centre. She graduated from Harvard Medical School and received a PhD in HIV immunology from the University of Oxford.
The guidelines can be downloaded and read.